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The Pseudomonas syringae type III-secreted effector HopZ1a is a member of the
HopZ/YopJ superfamily of effectors that triggers immunity in Arabidopsis. We have
previously shown that HopZ1a suppresses both local [effector-triggered immunity
(ETI)] and systemic immunity [systemic acquired resistance (SAR)] triggered by the
heterologous effector AvrRpt2. HopZ1a has been shown to possess acetyltransferase
activity, and this activity is essential to trigger immunity in Arabidopsis. HopZ1a
acetyltransferase activity has been reported to require the auto-acetylation of the
effector on a specific lysine (K289) residue. In this paper we analyze the relevance of
autoacetylation of lysine residue 289 in HopZ1a ability to suppress plant defenses, and
on the light of the results obtained, we also revise its relevance for HopZ1a avirulence
activity. Our results indicate that, while the HopZ1aK289R mutant is impaired to some
degree in its virulence and avirulence activities, is by no means phenotypically equivalent
to the catalytically inactive HopZ1aC216A, since it is still able to trigger a defense
response that induces detectable macroscopic HR and effectively protects Arabidopsis
from infection, reducing growth of P. syringae within the plant. We also present evidence
that the HopZ1aK289R mutant still displays virulence activities, partially suppressing both
ETI and SAR.
Keywords: type III secretion system, effector, ETI, suppression, plant defense, SAR, acetylation, Pseudomonas
syringae
Introduction
Many gram-negative pathogenic bacteria use a type III secretion system (T3SS) to secrete
proteins, known as effectors, directly inside the host cell cytosol. Type III effectors (T3Es)
modulate diverse processes inside the host, suppressing plant defense responses triggered
upon recognition of the pathogen (Gohre and Robatzek, 2008). One such defense is
triggered upon recognition of conserved pathogen-associated molecular patterns (PAMPs)
and is known as PTI (Boller and Felix, 2009). T3Es can be directly or indirectly detected
by the plant resistance proteins, triggering a second line of defense, a strong response
known as ETI that is typically accompanied by a type of programmed cell death referred
Abbreviations: DC3000, P. syringae pathovar tomato strain DC3000; ETI, effector-triggered immunity; HR, hypersensitive
response; PAMP, pathogen associatedmolecular patterns; PR1, pathogenesis related-1; PTI, PAMP-triggered immunity; T3SS,
type III secretion system.
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to as the hypersensitive response (HR). The ETI response
determines a severe restriction in pathogen growth (Chisholm
et al., 2006). Effectors triggering strong immunity were originally
named avirulence factors, as their expression by a pathogen
determines resistance against the disease (Mansfield, 2009).
Effectors can also suppress ETI, cell death and other HR-
associated phenomena, thus promoting pathogen growth and
the development of disease (Jones and Dangl, 2006). We have
shown that HopZ1a from Pseudomonas syringae pv. syringae is
one such effector (Macho et al., 2010). Heterologous expression
of HopZ1a from P. syringae pv. tomato DC3000 (hereafter
DC3000), suppresses RNA and protein accumulation of PR1,
triggered in Arabidopsis by this pathogen (Macho et al., 2010),
and partially suppresses the ETI triggered by the expression of the
heterologous effectors AvrRpt2, AvrRps4, and AvrRpm1 (Macho
et al., 2010). These defense suppression activities of HopZ1a are
similar to those described for the related Xanthomonas effector
AvrBsT (Kim et al., 2010, 2013; Szczesny et al., 2010). We
have also demonstrated that HopZ1a is capable of suppressing
systemic acquired resistance (SAR) triggered by either virulent
or avirulent bacteria (Macho et al., 2010). All these virulence
activities are fully dependent on HopZ1a C216 catalytic residue.
In turn, HopZ1a triggers SA and EDS1-independent immunity
in Arabidopsis (Lewis et al., 2010; Macho et al., 2010) upon
recognition by the ZAR-1 resistance gene (Lewis et al., 2010).
HopZ1a is a member of the YopJ/HopZ effector superfamily,
whose members share a conserved catalytic triad (C/H/D) and
have been shown to perform numerous biochemical activities,
mainly as proteases and/or acetyltransferases, with some effectors
such as YopJ displaying up to three different biochemical
functions concurrently (Orth et al., 2000; Mukherjee et al., 2006;
Sweet et al., 2007). To explain such multiplicity of activities, it has
been suggested that acetyltransferases and proteases might use
the same catalytic mechanism on different substrates (Mukherjee
et al., 2007). HopZ1a has been described to display cysteine
protease activity (Ma et al., 2006), but also acetyltransferase
activity on a number of plant target proteins, with the latter
activity requiring the plant cofactor phytic acid (Lee et al.,
2012; Jiang et al., 2013; Lewis et al., 2013). HopZ1a catalytic
triad cysteine (C216) is essential for all described virulence and
avirulence functions, as well as for its biochemical activities,
and a HopZ1aC216A mutant behaves as a catalytically inactive
mutant (Ma et al., 2006; Lewis et al., 2008; Macho et al., 2010;
Lee et al., 2012). Xanthomonas AvrBsT, the only other effector of
the YopJ/HopZ superfamily with ETI-suppressing activity, shares
with HopZ1a the biochemical activities, cofactor requirements,
and catalytic triad dependence on its virulence and avirulence
functions (Szczesny et al., 2010; Kim et al., 2013; Cheong et al.,
2014). HopZ1a has also been shown to autoacetylate in a lysine
residue (K289) conserved in some related effectors, with the
HopZ1aK289R mutant phenocopying the catalytically inactive
HopZ1aC216A mutant in respect to the acetyltransferase activity,
and also to its avirulence and some of its virulence functions (Lee
et al., 2012). Autoacetylation of such conserved lysine residue
was originally described for another member of the YopJ/HopZ
superfamily, Ralstonia effector PopP2 (Tasset et al., 2010). Auto-
acetylation of PopP2 is required to trigger a defense response
mediated by RRS1-R, a plant resistance protein that interacts with
PopP2 but is not acetylated by this effector (Tasset et al., 2010).
In this work, we analyze the requirement of HopZ1a K289
acetylation for HopZ1a suppression of ETI and SAR, as well as
its avirulence function, i.e., HopZ1a induction of ETI. We have
found that expression of HopZ1aK289R suppresses accumulation
of PR1 in local tissue, as well as SAR in distal tissues, although
the suppression activities of the mutant effector are not as
efficient as those achieved by expression of wild type HopZ1a.
Our results indicate that auto-acetylation of this residue is
important for full activity but not essential for suppression
of either ETI or SAR. Interestingly, we also found that the
K289R mutation does not abolish the onset of ETI upon
HopZ1a recognition, although it is required for full immunity.
The K289R mutation reduces but does not prevent HopZ1a-
mediated immunity from restricting growth of DC3000, in
contrast with mutation of the C216 catalytic residue. Similarly,
the K289R mutation reduces but does not abolish HopZ1a
induction of macroscopic HR, and more importantly, it does not
eliminate HopZ1a ability to effectively protect Arabidopsis against
infection with DC3000. Our results indicate that this residue
is important but not essential for HopZ1a activity, since its
mutation does not abrogate the effector virulence and avirulence
activities.
Materials and Methods
Bacterial Strains and Growth Conditions
Pseudomonas syringae pv. tomato DC3000 (Cuppels, 1986) and
derivatives carrying a plasmid (Table 1), as well as Agrobacterium
tumefaciens C58C1 (Deblaere et al., 1985), were grown at 28◦C
in Luria-Bertani (LB) medium. Antibiotics were used at the
following concentration: 10 µg/ml gentamicin and 15 µg/ml
kanamycin for P. syringae strains; 50µg/ml kanamycin, 50µg/ml
rifampicin and 5 µg/ml tetracycline for Agrobacterium. All plates
used to grow plant-extracted bacteria contained cycloheximide
(2 µg/ml) to prevent fungal contamination.
Plant Material and Bacterial Inoculations
Arabidopsis thaliana (Col-0) and the T-DNA insertion line zar1-
1 (Lewis et al., 2010) were grown in soil, or for disease symptom
development assays, in jiffy-7 (Jiffy Products Ltd., Norway). In
either case, they were grown in temperature-controlled chambers,
at 21◦C with a controlled photoperiod of 8 h light/16 h dark with
a light intensity of 200 µmol/m2/s. Nicotiana benthamiana was
grown in soil in temperature-controlled chambers, at 21◦Cwith a
controlled photoperiod of 16 h light/8 h dark with a light intensity
of 200 µmol/m2/s.
Competitive index and canceled-out assays were performed
as previously described for Arabidopsis (Macho et al., 2007).
Using a blunt syringe, 4- to 5-weeks-old plants were inoculated
with a 5 × 104 cfu (colony-forming unit)/ml mixed bacterial
suspension, containing equal numbers of wild type and effector-
expressing strains. Serial dilutions of the inoculum were plated
onto LB agar and LB agar with kanamycin to confirm dose
and relative proportion between the strains, which should be
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TABLE 1 | Plasmids used in this work.
Name Promoter Expressed
effectors
Resistance Reference
pAME30 nptII HopZ1a Amp, Km Macho et al. (2010)
pAME27 nptII HopZ1aC216A Amp, Km Macho et al. (2010)
pMAM1 nptII HopZ1aK289R Amp, Km This work
pAME8 nptII AvrRpt2 Amp, Km Macho et al. (2009)
pAME33 nptII HopZ1a +
AvrRpt2
Amp, Km Macho et al. (2010)
pAME34 nptII HopZ1aC216A
+ AvrRpt2
Amp, Km Macho et al. (2010)
pJRU10 nptII HopZ1aK289R
+ AvrRpt2
Amp, Km This work
pAME30Gm nptII HopZ1a Amp, Km,
Gm
This work
pAME27Gm nptII HopZ1aC216A Amp, Km,
Gm
This work
pMAM1Gm nptII HopZ1aK289R Amp, Km,
Gm
This work
pBINZ1 35S 6xHis-
HopZ1a
Km This work
pBINZ2 35S 6xHis-
HopZ1aC216A
Km This work
pBINZ3 35S 6xHis-
HopZ1aK289R
Km This work
close to one. We have previously established that two strains co-
inoculated in an equaled-number inoculum at a 5 × 104 cfu/ml
concentration, grow as they would when inoculated individually
(i.e., without any interference such as complementation or
dominant negative effects on the growth of each other). Thus, by
analyzing their growth within the same plant, we can carry out an
accurate and direct comparison between their respective growths,
by reducing plant-to plant and experimental deviations. At 2 or
4 days post-inoculation (dpi), three 10-mm-diameter leaf disks
were homogenized into 1 ml of 10 mM MgCl2, by mechanical
disruption. Bacteria were enumerated by plating serial dilutions
onto LB agar with cycloheximide, and LB agar with kanamycin
and cycloheximide, to differentiate the strains within the mixed
infection. Bacterial enumeration was carried out in the dilution
displaying between 50 and 500 colonies per plate. The CI is
defined as the mutant-to-wild type ratio within the output
sample divided by the mutant-to-wild type ratio within the input
(inoculum; Freter et al., 1981; Taylor et al., 1987). The canceled-
out index (COI) is calculated dividing the output ratio between
the strain expressing two effectors and the strain expressing one
effector, by their input ratio (Macho et al., 2010). Competitive and
canceled-out indices presented are the mean of three biological
replicates from at least three independent experiments (i.e., at
least nine biological replicates). Errors bars represent standard
error. Each CI or COI was analyzed using a homoscedastic and
two-tailed Student’s t-test and the null hypothesis: mean index
is not significantly different from one, or from other mean value
(P-value< 0.05).
For measuring SAR, plants were initially inoculated with
either 10 mM MgCl2 (mock), DC3000 or DC3000-expressing
effectors at 5 × 105 cfu/ml. After 2 dpi, secondary leaves were
inoculated with a 5 × 104 cfu/ml DC3000 suspension. Growth
of DC3000 was measured in secondary leaves at 4 dpi, as already
described.
For macroscopic HR assays, fully expanded leaves of 4-
to 5-weeks-old Arabidopsis plants were inoculated using a
blunt syringe with a 5 × 107 cfu/ml bacterial suspension, and
symptoms were documented at 20 or 24 h post-inoculation (hpi).
A minimum of 30 leaves was inoculated per strain and plant
genotype.
For transient expression assays in N. benthamiana, 5-
weeks-old plants were inoculated with an A. tumefaciens
C58C1 solution at OD600 0.5 in 10 mM MgCl2,
10 mM MES (SIGMA, USA), 200 µM 3′,5′-dimethoxy-4′-
hydroxyacetophenone (acetosyringone; SIGMA, USA) carrying
the corresponding binary plasmids (Table 1). Plants were
monitored fordevelopmentofmacroscopicHRandphotographed
at 48 h post-inoculation.
For protein extractions, two fully expanded Arabidopsis young
leaves were inoculated with either 10 mM MgCl2 (mock) or a
5 × 105 cfu/ml bacterial solution.
For symptom visualization, 3-weeks-old Arabidopsis
plants were sprayed with a bacterial suspension containing
5 × 107 cfu/ml in 10 mM MgCl2 containing 0.02% Silwet-L77
(Crompton Europe Ltd., UK). Plants were kept covered for 24 h
to keep humidity high.
Plasmid Generation
Plasmids used in this work are listed in Table 1. Parental vectors
and cloning intermediaries are described in this section.
HopZ1a K289R point mutation was generated following the
instructions for the QuikChange Lightning Multi Site-Directed
Mutagenesis Kit (Agilent Technologies, USA) using vectors
pAME30 and pAME33 as templates, to generate pMAM1
and pJRU10, respectively. The primers used were Z1aM1
(CCGGTGGATTTTTATAGGCATGGCGCTTCGCTG) and
Z1aM2 (CAGCGAAGCGCCATGCCTATAAAAATCCACCGG).
The point mutation was verified by sequencing.
For COI assays, a fragment containing a gentamicin
resistance cassette was excised from pMGm (Murillo et al.,
1994) using KpnI and cloned into the corresponding site of
pAME30 (HopZ1a), pAME27 (HopZ1aC216A), and pMAM1
(HopZ1aK289R), to generate pAME30Gm, pAME27Gm,
and pMAM1Gm, respectively. The gentamicin resistance
cassette allowed antibiotic selection of strains carrying these
plasmids versus strains carrying plasmids conferring kanamycin
resistance.
Vectors used for in planta transient expression assays were
generated by means of an intermediate cloning step using
expression vector pET28a(+) (Novagen, USA). HopZ1a,
HopZ1aC216A and HopZ1aK289R were amplified by PCR
with the iProof High-Fidelity PCR Kit (BioRad, USA), using
plasmids pAME30, pAME27, and pMAM1 as templates, and
primers Z1pET-F (AACATATGGGAAATGTATGCGTCG)
and Z1pET-R (AAGGATCCTTAGCGCTGCTCTTCGGC).
PCR-amplified DNA fragments, encoding the corresponding
ORFs were digested with NdeI and BamHI and cloned into
the corresponding sites of expression vector pET28a(+). The
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resulting vectors pET28-Z1a, pET28-C2, and pET28-K2 carry
HopZ1a, HopZ1aC216A, and HopZ1aK289R as 6xHis N-terminal
fusion proteins, respectively. The ORFs for 6xHis-HopZ1a,
6xHis-HopZ1aC216A, and 6xHis-HopZ1aK289R were excised
from pET28-Z1a, pET28-C2, and pET28-K2 using XbaI and
BamHI, and cloned into the corresponding sites of binary vector
pBINX1 (Sanchez-Duran et al., 2011): the resulting vectors were
designated pBINZ1, pBINZ2, and pBINZ3, respectively.
Plant Protein Extraction and Western Blot
Approximately 100 µg of leaf tissue were harvested, frozen
into liquid nitrogen and ground into 100 µl of extraction
buffer [10 mM Tris-HCl pH 7.4, 150 mM NaCl and EDTA-
free plant protease inhibitor cocktail (Roche, Germany)]. The
resulting homogenate was centrifuged at 20000 g for 10 min at
4◦C. Soluble supernatant was separated and centrifuged again
to ensure absence of insoluble debris. Protein concentration
of the soluble supernatant was determined by the BioRad
protein assay (BioRad, USA). Ten micrograms of each protein
sample, unless otherwise stated, were resolved on 12% acrylamide
SDS-PAGE gels (Mini protean, BioRad, USA) and transferred
to PVDF membranes (Millipore, USA). Western blots for
immunodetection of PR1 were carried out using standard
methods, with a 1:5000 dilution of anti-PR1 antibody and 1:10000
dilution of a secondary Anti-Rabbit antibody (SIGMA, USA).
Membranes were developed using the BioRad Clarity Western
ECL Substrate (BioRad, USA) following instructions from the
manufacturer. The anti-PR1 serum was originally described by
Wang et al. (2005).
Results
HopZ1aK289R Suppresses Local PR1
Accumulation Triggered by DC3000
We have previously shown that HopZ1a suppresses DC3000-
triggered PR1 protein accumulation, and that this suppression
requires its catalytic cysteine C216 residue (Macho et al.,
2010). To analyze the potential effect of the K289R mutation
on HopZ1a activity, we inoculated Arabidopsis Col-0 plants
with DC3000, DC3000 expressing HopZ1a, or DC3000
expressing either the catalytically inactive HopZ1aC216A
mutant or the HopZ1aK289R mutant, and compared the
levels of PR1 accumulation in local tissue 48 h after infection
(hpi).
In keeping with our previous results (Macho et al., 2010),
PR1 accumulated to similar levels in leaves inoculated with
DC3000 or DC3000 expressing HopZ1aC216A, while PR1
accumulation was clearly reduced in plants inoculated with
DC3000 expressing HopZ1a (Figure 1). When leaves were
inoculated with DC3000 expressing the HopZ1aK289R mutant
protein, PR1 levels were slightly reduced compared to those
observed following inoculation with DC3000 or DC3000
expressing HopZ1aC216A, however, this reduction was not as
substantial as that achieved by the wild type version of the effector
(Figure 1). These results indicate that the HopZ1aK289R mutant is
still able to suppress local PR1 accumulation elicited by virulent
FIGURE 1 | HopZ1a-mediated suppression of local DC3000-triggered
PR1 accumulation is reduced but not abolished by the K289R
mutation.Western blot showing PR1 accumulation in Col-0 leaves
inoculated with 5 × 105 cfu/ml of DC3000, DC3000 expressing HopZ1a
(pAME30), or DC3000 expressing the mutant derivatives HopZ1aC216A
(pAME27) or HopZ1aK289R (pMAM1). Ten micrograms of total protein were
loaded per sample, and Coomassie staining is shown as loading control. The
signal intensity for each band was quantified using Fiji distribution of ImageJ
software and is shown below the blot. The experiment was repeated three
times with similar results.
bacteria in the context of a compatible interaction, and suggest
that the K289R mutation does not render the effector inactive, in
contrast to the C216A mutation.
HopZ1aK289R Suppresses AvrRp2-Triggered
Immunity
We have also described previously that HopZ1a suppresses the
local accumulation of PR1 that accompanies the onset of the
ETI triggered by the expression of the heterologous effector
AvrRpt2 by DC3000 (Macho et al., 2010). HopZ1a suppression
of AvrRpt2-induced PR1 accumulation is a virulence activity that
also depends on the HopZ1a catalytic cysteine C216 (Macho et al.,
2010). To analyze the potential effect of the K289R mutation
on HopZ1a activity, we inoculated Arabidopsis Col-0 plants
with DC3000 expressing AvrRpt2, or DC3000 co-expressing
AvrRpt2 and either HopZ1a, HopZ1aC216A, or HopZ1aK289R,
and compared the levels of PR1 in the inoculated tissue at
24 hpi.
PR1 accumulated to similar levels in leaves inoculated with
DC3000 expressing AvrRpt2 or DC3000 co-expressing AvrRpt2
and HopZ1aC216A, while PR1 accumulation was clearly reduced
in leaves inoculated with DC3000 co-expressing AvrRpt2 and
HopZ1a (Figure 2A). In leaves inoculated with DC3000 co-
expressing AvrRpt2 and the HopZ1aK289R mutant protein, we
could not detect differences in PR1 accumulation in comparison
to leaves inoculated with either DC3000 expressing AvrRpt2
alone or with HopZ1aC216A (Figure 2A)
HopZ1a suppression of AvrRpt2-triggered defense responses
has also been demonstrated in Arabidopsis by directly comparing
the growth attenuation determined by the individual expression
of each effector, with the growth attenuation determined by their
simultaneous expression (Macho et al., 2010). Thus, we also
analyzed the impact of the K289R mutation on the suppression
of AvrRpt2-triggered growth restriction. To do so we performed
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FIGURE 2 | HopZ1aK289R partially suppresses AvrRpt2-triggered
immunity. (A) Western blot showing PR1 accumulation in Col-0 leaves
inoculated with 5 × 105 cfu/ml of DC3000 expressing AvrRpt2 (pAME8)
alone or co-expressing AvrRpt2 with HopZ1a (pAME33), HopZ1aC216A
(pAME34), or HopZ1aK289R (pJRU10). Ten micrograms of total protein were
loaded per sample, and Coomassie staining is shown as loading control.
The signal intensity for each band was quantified using Fiji distribution of
ImageJ software and is shown below the blot. The experiment was
repeated twice with similar results. (B) Canceled-out indices (COIs)
measuring growth within a mixed infection of DC3000 co-expressing
AvrRpt2 and any of the three HopZ1a variants: wild-type HopZ1a
(pAME33), HopZ1aC216A (pAME34) or HopZ1aK289R (pJRU10), in relation to
growth of DC3000 expressing only the corresponding HopZ1a: wild-type
HopZ1a (pAME30Gm), HopZ1aC216A (pAME27Gm), or HopZ1aK289R
(pMAM1Gm). COIs are calculated as the output ratio between the strain
expressing both effectors and the strain expressing just one, divided by
their input ratio. Each COI value represents the means of two independent
experiments with three biological replicates each. Error bars represent the
standard error. Mean values marked with the same letter are not
significantly different from each other as established by Student’s t-test
(P < 0.05).
mixed infections and calculated the COI, a modification of the
competitive index (Beuzón andHolden, 2001), previously applied
to this purpose (Macho et al., 2010). COIs directly measure the
differences in growth, within the same plant, between a strain
expressing one of the effectors and a strain co-expressing both
effectors, i.e., differences in growth of co-inoculated DC3000
expressing HopZ1a and DC3000 co-expressing HopZ1a and
AvrRpt2. Thus, we can directly compare how expression of
AvrRpt2 affects growth of DC3000 in the presence of HopZ1a or
any of its mutant derivatives, with growth of DC3000 expressing
only the HopZ1a version. As HopZ1a is expressed in both
strains, the growth reduction it causes in Col-0 is canceled
out as it equally affects both strains (Macho et al., 2010), and
any difference in growth detected between the strain expressing
both effectors and the strain expressing only the HopZ1a
version, would be due to a growth restriction determined by
the unsuppressed defenses triggered against AvrRpt2. A diagram
illustrating this analysis is included as supplementary material
(Supplementary Figure S1).
As previously reported (Macho et al., 2009, 2010) DC3000
co-expressing AvrRpt2 and HopZ1a displayed a small although
significant growth attenuation compared to that of co-inoculated
DC3000 only expressing HopZ1a (COI= 0.69± 0.09; Figure 2B,
Supplementary Figure S1), despite the fact that AvrRpt2 alone
triggers a 50–100 fold growth attenuation when expressed
by DC3000 from the same plasmid. This result is expected
since HopZ1a is capable of partially suppressing the defense
response triggered by AvrRpt2 in Arabidopsis (Macho et al.,
2010). Accordingly, growth of DC3000 co-expressing AvrRpt2
and the HopZ1aC216A catalytic mutant was almost 50 fold
lower than the growth of DC3000 expressing HopZ1aC216A
alone (COI = 0.03 ± 0.01; Figure 2B, Supplementary Figure
S1). However, growth of DC3000 co-expressing AvrRpt2
and the HopZ1aK289R mutant was only a 10-fold lower
than growth of the strain expressing HopZ1aK289R alone
(COI = 0.09 ± 0.01). These results indicate that mutation
K289R decreases, but does not abrogate, HopZ1a ability
to suppress AvrRpt2-triggered restriction of growth, since
co-expression of AvrRpt2 and HopZ1aK289R causes a smaller
attenuation of growth than co-expression of AvrRpt2 and the
HopZ1aC216A catalytic mutant or expression of AvrRpt2 alone
(Figure 2B).
Our results (Figure 2B) indicate that, unlike the catalytically
inactive HopZ1aC216A mutant derivative, HopZ1aK289R mutant
is still able to suppress AvrRpt2-triggered immunity, since it
still suppresses AvrRpt2-triggered restriction of growth. The
fact that we do not detect suppression of PR1 protein in
plants inoculated with DC3000 expressing the HopZ1aK289R
mutant may indicate that our assay is not sensitive enough,
or that the association between the PR1 accumulation and
growth restriction associated to AvrRpt2-triggered immunity is
not linear. To this regards, a similar lack of linearity in the
association between PR1 accumulation and growth restriction
during induction of SAR has been previously shown (Macho
et al., 2010).
HopZ1a Partially Suppresses
AvrRpt2-Triggered Immunity in zar1-1 Mutant
Plants
Results presented in Figure 2B are in agreement with
our previous report concluding that HopZ1a partially
suppresses AvrRpt2-triggered ETI in Arabidopsis (Macho
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et al., 2010). However, it has been recently reported that
HopZ1a transgenic expression in zar1-1 plants does not
interfere with AvrRpt2-induced macroscopic HR (Lewis
et al., 2014). HopZ1a-triggered immunity in Arabidopsis
is dependent on the ZAR1 resistance protein (Lewis et al.,
2010). In the light of this report we decided to analyze the
ability of HopZ1a to suppress AvrRpt2-triggered immunity
in the absence of HopZ1a-triggered immunity. To this
purpose, we analyzed HopZ1a impact on AvrRpt2-triggered
restriction of growth in a zar1-1 plant genotype (Lewis et al.,
2010).
Using CI assays, we compared growth of DC3000 expressing
HopZ1a or AvrRpt2 with growth of DC3000 in zar1-1 plants,
to determine the growth restriction associated to ETI responses
against each of these effectors in the mutant background
(Figure 3). Growth of DC3000 expressing HopZ1a was very
similar to growth of DC3000 in zar1-1 plants (CI = 0.72 ± 0.09;
Figure 3). Whereas, as expected since AvrRtp2-triggered
immunity is independent of ZAR1, the expression of this
effector in DC3000 still determined a strong growth attenuation
(CI = 0.03 ± 0.01; Figure 3). However, co-expression of
AvrRpt2 and HopZ1a in zar1-1 plants caused significantly less
growth attenuation (CI = 0.10 ± 0.03) than that caused by
expression of AvrRpt2 alone (Figure 3), demonstrating that
HopZ1a suppression of AvrRpt2-triggered immunity takes place
in the absence of HopZ1a-triggered immunity, and is not
caused by an overlap or interference between the two ETI
pathways.
FIGURE 3 | HopZ1a suppresses AvrRpt2-triggered ETI in zar1-1 plants.
Competitive indices (CIs) measuring growth within a mixed infection of
DC3000 expressing HopZ1a (Z1a, pAME30), AvrRpt2 (pAME8) or
co-expressing both (Z1a + AvrRpt2, pAME33) in relation to growth of
DC3000. CIs are calculated as the output ratio between the strain expressing
the effector(s) and DC3000, divided by their input ratio. Each CI value
represents the means of three independent experiments with three biological
replicates each. Error bars represent the standard error. Mean values marked
with the same letter were not significantly different from each other as
established by Student’s t-test (P < 0.05).
HopZ1aK289R Retains the Ability to Suppress
Systemic Acquired Resistance (SAR) Triggered
by DC3000 Infection
Both virulent and avirulent bacteria can trigger SAR, a
defense response elicited in distal (systemic) tissues as a
result of local infection. Activation of SAR determines both
systemic accumulation of PR1, and restriction of growth of
newly incoming bacteria (Cameron et al., 1994). We have
previously shown that HopZ1a expression suppresses SAR
triggered by DC3000, and that such suppression requires
HopZ1a catalytic cysteine C216 (Macho et al., 2010). To
determine whether the HopZ1aK289R mutant retained HopZ1a
ability to suppress SAR, we first analyzed the effect of
the mutation K289R in HopZ1a ability to suppress SAR-
associated restriction of growth of newly incoming bacteria.
We inoculated primary leaves with either 10 mM MgCl2
(mock), DC3000, or DC3000 expressing HopZ1a or the
corresponding mutant derivatives HopZ1aC216A or HopZ1aK289R
(Figure 4A). Two days after inoculation of primary leaves,
distal leaves were inoculated with DC3000, and 4 days after
this second inoculation we monitored the growth of DC3000.
Figure 4A shows that, as previously described, pre-inoculation
of primary leaves with either DC3000 or DC3000 expressing
the catalytically inactive mutant HopZ1aC216A triggered SAR
to equivalent levels, since growth of DC3000 in distal
leaves was similarly attenuated in both cases. In contrast,
pre-inoculation with DC3000 expressing HopZ1a did not
result in detectable attenuation of growth of DC3000 in
distal leaves, since it did not show significant differences
with that observed in mock pre-inoculated leaves, thus
confirming the reported HopZ1a suppression of SAR (Macho
et al., 2010). Systemic leaves from plants pre-inoculated with
DC3000 expressing HopZ1aK289R displayed DC3000 cfu values
significantly different to those reached in plants pre-inoculated
with DC3000 expressing HopZ1aC216A, but similar to those
reached in plants pre-inoculated with DC3000 expressing
HopZ1a (Figure 4A), supporting the notion that auto-acetylation
of HopZ1a on K289 is not required for suppression of SAR in
Arabidopsis.
To determine how the HopZ1aK289R mutant ability to
suppress SAR correlates with suppression of PR1 accumulation
in systemic tissue, we used western blot analysis to analyze
accumulation of PR1 in systemic leaves of plants pre-inoculated
with DC3000 or DC3000 expressing the different versions of
HopZ1a. In keeping with previous results (Macho et al., 2010),
expression of HopZ1a in DC3000 suppresses PR1 accumulation
in systemic tissues, since distal leaves of plants pre-inoculated
with DC3000 expressing HopZ1a displayed a strong reduction
of PR1 accumulation when compared to plants pre-inoculated
with DC3000 (Figure 4B). This suppression is dependent on
HopZ1a catalytic cysteine, since systemic leaves of plants pre-
inoculated with DC3000 expressing HopZ1aC216A displayed PR1
levels that were higher than those observed in plants pre-
inoculated with DC3000 expressing HopZ1a (Figure 4B). As
previously reported (Macho et al., 2010) the C216A mutation
did not entirely abolish HopZ1a ability to suppress PR1
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FIGURE 4 | HopZ1a-mediated suppression of SAR is reduced but not
abolished by the K289R mutation. (A) Growth of DC3000 inoculated in
secondary leaves of plants pre-inoculated in primary leaves by infiltrating
either a 10 mM MgCl2 solution (Mock), or 5 × 105 cfu/ml of DC3000,
DC3000 expressing HopZ1a (pAME30), or DC3000 expressing the mutant
derivatives HopZ1aC216A (pAME27) or HopZ1aK289R (pMAM1). Two days
post-inoculation of primary leaves, secondary leaves were inoculated with
5 × 104 cfu/ml of DC3000, and growth was measured at 4 days
post-inoculation of the secondary leaves. The experiment was repeated four
times with similar results, and the results shown correspond to a
representative experiment. The values shown represent the means of 5
biological replicates. Error bars represent the standard error. Values marked
with the same letter were not significantly different from each other as
established by Student’s t-test (P < 0.05). (B) Western blot analysis for
immunodetection of PR1 on distal non-inoculated leaves, 2 days after
inoculating primary leaves with either 10 mM MgCl2 (Mock), or 5 × 105 cfu/ml
of DC3000, DC3000 expressing HopZ1a (pAME30), or DC3000 expressing
the mutant derivatives HopZ1aC216A (pAME27) or HopZ1aK289R (pMAM1). Ten
micrograms of total protein were loaded per sample, and Coomassie staining
is shown as loading control. The signal intensity for each band was quantified
using Fiji distribution of ImageJ software and is shown below the blot. The
experiment was repeated twice with similar results.
accumulation, since the systemic levels of PR1 in plants pre-
inoculated with DC3000 expressing HopZ1aC216A did not reach
the levels observed in plants pre-inoculated with DC3000
(Figure 4B). Interestingly, when primary leaves were inoculated
with DC3000 expressing HopZ1aK289R, the accumulation of PR1
in distal leaves reached levels that were intermediate between
those elicited by DC3000 expressing HopZ1aC216A and DC3000
expressing wild type version of the effector (Figure 4B). These
results indicate that the HopZ1aK289R mutant is still able to
partially suppress systemic accumulation of PR1 in response to
DC3000.
HopZ1aK289R Triggers ETI in Arabidopsis and
N. benthamiana
Inoculation of Arabidposis leaves with a 5 × 107 cfu/ml of
DC3000 expressing HopZ1a induces macroscopic HR symptoms
in Arabidopsis leaves, which are absent in leaves inoculated with
the same dose of DC3000 expressing the HopZ1aC216A catalytic
mutant (Lewis et al., 2008; Macho et al., 2010). It has been
reported that the mutation K289R completely prevents HopZ1a-
triggered HR, which cannot be detected when expressing the
mutant effector under the control of its own promoter (Lee et al.,
2012). However, considering that our results presented above
indicate that such mutation does not render the effector entirely
inactive, we wondered whether HopZ1aK289R could still be able
to trigger immunity in Arabidopsis.
To analyze whether the HopZ1aK289R mutant was able to
trigger macroscopic HR in Arabidopsis, we inoculated leaves
with 5 × 107 cfu/ml of DC3000, DC3000 expressing HopZ1a,
or DC3000 expressing either HopZ1aC216A or HopZ1aK289R
mutant derivatives, and monitored HR development by
20–24 hpi (Figure 5A). Development of macroscopic HR
requires a rather strong ETI response, which might not be
reached by lower levels of effector-expression (Macho et al.,
2009), thus we expressed HopZ1a and its mutant derivatives
under the control of the strong constitutive nptII promoter,
to factor in the chance of an stronger effector-expression
allowing detection of a mild ETI. In keeping with previous
reports (Lewis et al., 2008; Macho et al., 2010), a clear HR
was detected in plants inoculated with DC3000 expressing
HopZ1a, while no HR could be detected in leaves inoculated
with either DC3000 or DC3000 expressing HopZ1aC216A
(Figure 5A). Interestingly, leaves inoculated with DC3000
expressing HopZ1aK289R displayed noticeable macroscopic HR
(Figure 5A). As expected from previous reports (Lewis et al.,
2010, 2014), inoculation of zar1-1 leaves with these strains did
not induce any visible cell death symptom (Supplementary
Figure S2).
The ETI triggered in Arabidopsis against HopZ1a determines
a strong restriction of bacterial growth that can be measured
using competitive index assays (CIs), in mixed infections
of DC3000 co-inoculated with DC3000 expressing HopZ1a
(Macho et al., 2009, 2010). To further investigate the impact
of the K289R mutation in HopZ1a activation of ETI in
Arabidopsis, we performed CI assays by co-inoculating
Arabidopsis plants with DC3000 and DC3000 expressing
HopZ1a, HopZ1aC216A, or HopZ1aK289R (Figure 5B). As
previously described (Macho et al., 2010), a clear growth
attenuation was measured for DC3000 expressing HopZ1a in
comparison with co-inoculated DC3000 (CI = 0.03 ± 0.01),
while no significant attenuation was detected for DC3000
expressing HopZ1aC216A catalytically inactive (CI = 0.91 ± 0.10;
Figure 5B). In contrast, DC3000 expressing HopZ1aK289R
displayed a small attenuation of growth (CI = 0.46 ± 0.10),
significantly smaller than that measured for DC3000 expressing
HopZ1a, but significantly different from the absence of
attenuation observed for HopZ1aC216A-expressing DC3000
bacteria (Figure 5B).
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FIGURE 5 | HopZ1aK289R triggers ETI. (A) Hypersensitive response (HR) to
hand-infiltration of Col-0 leaves with bacterial suspensions containing
5 × 107 cfu/ml of DC3000 alone or DC3000 expressing HopZ1a (pAME30),
or each of its mutant derivatives HopZ1aC216A (pAME27) or HopZ1aK289R
(pMAM1). Photographs were taken 24 h post-inoculation. Images are
representative of at least 30 inoculated leaves per strain and experiment. The
experiment was repeated twice with similar results. (B) Competitive indices
(CIs) measuring growth within a mixed infection of DC3000 expressing
HopZ1a (Z1a, pAME30), or each of its mutant derivatives HopZ1aC216A
(Z1aC216A, pAME27) or HopZ1aK289R (Z1aK289R, pMAM1), in relation to
growth of DC3000. CIs are calculated as the output ratio between the strain
expressing the effector and DC3000, divided by their input ratio. Each CI
value represents the means of three independent experiments with three
biological replicates each. Error bars represent the standard error. Mean
values marked with the same letter were not significantly different from each
other as established by Student’s t-test (P < 0.05). (C) Development of HR
following transient expression of either 6xHis-HopZ1a (pBINZ1) or each of its
mutant derivatives 6xHis-HopZ1aC216A (pBINZ2) or 6xHis-HopZ1aK289R
(pBINZ3). Nicotiana benthamiana leaves were inoculated with Agrobacterium
tumefaciens C58C1 carrying binary plasmids encoding the corresponding
effector genes. Pictures were taken 48 h post-inoculation. The experiment
was repeated three times with similar results.
In addition to triggering HR in Arabidopsis, HopZ1a has
been shown to trigger macroscopic HR in N. benthamiana
leaves when transiently expressed using Agrobacterium (Ma et al.,
2006; Lewis et al., 2008). We expressed HopZ1a and its mutant
derivatives HopZ1aC216A and HopZ1aK289R in N. benthamiana
leaves, under the control of a constitutive promoter, by using
Agrobacterium-mediated transient expression, and monitored
HR symptoms at 40 h after Agrobacterium inoculation. While
transient HopZ1aC216A overexpression did not result in HR
elicitation whatsoever, HopZ1aK289R overexpression elicited an
HR of a similar intensity to that elicited by overexpressing
HopZ1a (Figure 5C).
Taken together, results shown in Figure 5 indicate that auto-
acetylation of HopZ1a in its lysine 289 contributes, but it is not
essential, to trigger ETI in Arabidopsis.
HopZ1aK289R-Triggered Defenses Effectively
Protects Arabidopsis against Disease
Development
We have previously shown that resistance triggered in
Arabidopsis by the expression of HopZ1a efficiently protects
plants from DC3000 infection, resulting in the absence
of virulence-associated disease symptoms (Macho et al.,
2010). To analyze whether the defense response triggered
against HopZ1aK289R mutant is sufficient to stymie DC3000
disease in Arabidopsis, we monitored development of disease
symptoms at 4–6 dpi on plants spray-inoculated with DC3000,
DC3000 expressing HopZ1a, or DC3000 expressing either
HopZ1aC216A or HopZ1aK289R mutant derivatives. As expected
from previous results (Macho et al., 2010), plants sprayed
with either DC3000 or DC3000 expressing HopZ1aC216A
displayed noticeable disease symptoms, namely chlorosis and
stunted growth, while plants sprayed with DC3000 expressing
HopZ1a did not (Figure 6). Interestingly, plants sprayed with
DC3000 expressing HopZ1aK289R did not display chlorosis and
only a slightly reduction in plant growth could be observed
(Figure 6).
These results clearly show that the HopZ1aK289R mutant
triggered-resistance effectively protects Arabidopsis plants from
disease.
Discussion
HopZ1aK289R Triggers ETI in Arabidopsis and
N. benthamiana and Effectively Protects
Arabidopsis against Disease Development
Results described in this paper indicate that the HopZ1aK289R
mutant is still able to trigger a defense response that induces
macroscopic HR (Figure 5) and, more importantly, effectively
protects Arabidopsis from infection (Figure 6). While our results
in respect to HopZ1aK289R mutant triggering macroscopic HR
are at variance with those described previously (Lee et al.,
2012), this discrepancy can be due to differences in effector
levels, since we express HopZ1a under the control of a
strong constitutive promoter, and macroscopic HR symptoms
can be quite dependent on threshold levels of the eliciting
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FIGURE 6 | Expression of HopZ1aK289R from DC3000 protects Col-0
plants against disease. Virulence symptoms caused by spray-inoculated
DC3000, or DC3000 expressing HopZ1a (pAME30), or each of its mutant
derivatives HopZ1aC216A (pAME27) or HopZ1aK289R (pMAM1). Arabidopsis
plants were sprayed with bacterial suspensions containing 5 × 107 cfu/ml in
0.02% Silwet L-77, and photographed 6 days post-inoculation. The experiment
was repeated three times using five plants per strain, and representative images
are shown.
effectors (Macho et al., 2009). While the development of
macroscopic HR symptoms after high-dose bacterial inoculation
is a good measure of the ability of an effector to trigger a
defense response, the protection from infection after a low-
dose inoculation may reflect more accurately the physiological
significance of such defense response for the plant. In this respect,
results shown in Figure 6 support the notion that the K289R
mutation does not abrogate HopZ1a avirulence activity. It is
important to notice that in neither of these assays, regarding
induction of macroscopic HR or protection against disease
development, did the catalytically inactive HopZ1aC216A trigger
any defense response whatsoever, regardless of being expressed
under the control of the same strong promoter, supporting
the notion that HopZ1aK289R activity is not an artifact due to
overexpression.
HopZ1aK289R Suppresses DC3000-Triggered
Basal Immunity
Results described in this paper indicate that the HopZ1aK289R
mutant retains its ability to suppress basal immunity triggered
by DC3000, since it can partially suppress DC3000-triggered
local and systemic PR1 accumulation (Figures 1 and 4), as well
as DC3000-triggered SAR-dependent restriction of growth in
systemic tissues (Figure 4).
The fact that PR1 accumulation against DC3000 requires a
functional T3SS (Macho et al., 2010) suggests that it is due to
weak ETI-like defenses. However, the implication of PTI cannot
be ruled out, since the level of PR1 accumulated in response to
PAMPs in the attenuated T3SS mutant could be below the level of
detection. In regards to this, a recent report demonstrates that
HopZ1a can indeed suppress DC3000-triggered PTI response
when overexpressed in transgenic Arabidopsis plants (Lewis et al.,
2014). Additionally, the related effector AvrBsT can also suppress
the PTI triggered by DC3000 infection in tomato, as shown by
a lower accumulation of PR1 in the infected plants (Kim et al.,
2010).
Previous reports have suggested that the K289R mutation
completely abrogates HopZ1a virulence activity, since
heterologous expression of the corresponding mutant effector
in P. syringae pv. cilantro 0788-9 did not contribute to the
growth of the expressing strain in the Arabidopsis zar1-1
background (Lee et al., 2012). However, the rather modest
growth rate achieved in Arabidopsis by Pseudomonas strain
0788-9, together with the limited contribution of wild type
HopZ1a to such growth, might be limiting the sensitivity of such
assay. Using a wider array of virulence assays, we demonstrate
that the K289R mutation does not abolish HopZ1a virulence
activity.
HopZ1a Suppresses AvrRpt2-Triggered
Immunity in the Absence of HopZ1a-Triggered
Immunity
Our results demonstrate that HopZ1a suppression of AvrRpt2-
triggered immunity takes place in the absence of HopZ1-
triggered immunity (Figure 3), and it is therefore not a
consequence of an overlap or interference between the defense
responses triggered by these effectors. This notion was previously
supported by the fact that AvrRpt2 does not alter HopZ1a-
triggered restriction of growth in rps2 plants, where AvrRpt2 does
not trigger resistance but still displays virulence activity (Macho
et al., 2010). This is in disagreement with a recent report based
on transgenic overexpression of HopZ1a in zar1-1 plants where
it has been shown to suppress PTI, but not to prevent the onset
of macroscopic HR (Lewis et al., 2014). However, such a strong
suppression of PTI could alter potentially the ETI response of the
transgenic lines.
HopZ1aK289R Suppresses AvrRpt2-Triggered
ETI
Effector-triggered immunity suppression is a key virulence
activity of HopZ1a that is only partly affected by the K289R
mutation, while being completely eliminated in the catalytically
inactive HopZ1aC216A mutant. The related Xanthomonas effector
AvrBsT has also been shown to suppress the ETI induced
in pepper plants by a second Xanthomonas effector, AvrBs1
(Szczesny et al., 2010). In fact, the demonstrations of the ETI-
suppressing activities of AvrBsT and HopZ1a were presented
simultaneously, becoming the first known effectors belonging to
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the YopJ/HopZ family to display such virulence function (Macho
et al., 2010; Szczesny et al., 2010). The ETI-suppression ability of
AvrBsT is also dependent on its catalytic cysteine (Szczesny et al.,
2010). However, the activity of the AvrBsT mutant equivalent to
HopZ1aK289R has only been assayed by heterologous expression
in the interaction model based on Pseudomonas DC3000 and
the Arabidopsis Pi-0 ecotype, where it does not display any
virulence function (Cheong et al., 2014). In view of the new
results presented here, and the similarities between HopZ1a and
AvrBsT, it would be interesting to analyze the performance of
the AvrBsTK282R mutant in pepper plants, where it displays
ETI-suppression abilities.
ZAR1-Mediated Resistance against HopZ1a
HopZ1a has been reported in turn to modestly enhance the
growth of DC3000 in zar1-1 plants (Lewis et al., 2010) and to
modestly decrease it (Jiang et al., 2013), in both cases differences
in growth were statistically significant but within the same log.
In our experimental conditions growth of DC3000 expressing
HopZ1a was close to that of DC3000 in zar1-1 plants, albeit
slightly decreased (Figure 3), since the CI of DC3000 expressing
HopZ1a in mixed infection with DC3000 (CI = 0.72 ± 0.09)
was statistically different from 1.0. Our results are therefore in
agreement with the observations of (Jiang et al., 2013). The
disparity with the results from the first report (Lewis et al.,
2010) could be due to differences in experimental settings,
however, the existence of a residual defense against HopZ1a in
the Arabidopsis zar1-1 background cannot be ruled out. Such
residual defense could be either due to residual activity of a
truncated ZAR1 protein, or to a weak recognition by a second
resistance protein, as described for other effectors (Saucet et al.,
2015).
HopZ1a Acetyltransferase Activity
On view of the results presented in this paper, the absolute
requirement of the K289 lysine residue for HopZ1a activity can
be discarded. In fact, it has recently been suggested in relation
to the closely related effector HopZ1c (Lewis et al., 2014) that
the C-terminal third of the HopZ family might be dispensable
for acetyltransferase activity, or that HopZ1c may use water
instead of acetyl-CoA during its enzymatic reaction, resulting in
hydrolysis of substrates rather than acetylation, in an alternative
catalytic mechanism suggested by Mukherjee et al. (2007).
Furthermore, although the described autoacetylation site of
HopZ1a is a lysine residue, the only HopZ1a interacting protein
where the acetylated residues have been identified, namely the
pseudokinase ZED1, is acetylated on threonine residues rather
than lysines (Lewis et al., 2013). It seems therefore likely that
HopZ1a might display acetyltransferase activity on amino acid
residues, such as serine or threonine, as it is the case with YopJ,
the archetypal effector of the YopJ/HopZ superfamily (Mukherjee
et al., 2006).
Results presented to date for several YopJ/HopZ effectors
do not support a consistent association between their
autoacetylation at the conserved lysine residue and their
transacetylation activities. For instance, AvrBsT maintains the
autoacetylation activity in the absence of the conserved lysine
residue, which is, however, essential for the acetylation of one
of its described targets (Cheong et al., 2014). On the other hand,
prior autoacetylation of YopJ is not required for acetylation
of MEK, one of its described targets (Mittal et al., 2010). This
opens the possibility that the said lysine residue and/or its
autoacetylation, while contributing to the overall function of
the effectors, is not essential for all their activities in planta.
Considering the various targets proposed for each of the effectors
belonging to the YopJ/HopZ superfamily, and the numerous
biochemical activities assigned, sometimes concurrently, to said
effectors (Orth et al., 2000; Hotson and Mudgett, 2004; Ma et al.,
2006; Mukherjee et al., 2006; Sweet et al., 2007; Szczesny et al.,
2010; Tasset et al., 2010; Zhou et al., 2011; Lee et al., 2012; Jiang
et al., 2013; Lewis et al., 2013; Cheong et al., 2014), it is tempting
to speculate that their molecular mechanisms in planta might
be manifold, and therefore that the conserved lysine residue
and/or its autoacetylation might not be required for all targets or
activities. The resultant of all these activities on numerous targets
would be observed as virulence or avirulence manifestations
on a given plant model, and might be behind the intermediate
phenotypes described for the HopZ1aK289R mutant in this
paper.
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